213 related articles for article (PubMed ID: 15277582)
1. A novel nonpeptide antagonist of the kinin B1 receptor: effects at the rabbit receptor.
Morissette G; Fortin JP; Otis S; Bouthillier J; Marceau F
J Pharmacol Exp Ther; 2004 Dec; 311(3):1121-30. PubMed ID: 15277582
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953
[TBL] [Abstract][Full Text] [Related]
3. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
Morissette G; Bouthillier J; Marceau F
Biol Chem; 2006 Feb; 387(2):189-94. PubMed ID: 16497151
[TBL] [Abstract][Full Text] [Related]
4. Role of the mitogen-activated protein kinases in the expression of the kinin B1 receptors induced by tissue injury.
Larrivée JF; Bachvarov DR; Houle F; Landry J; Huot J; Marceau F
J Immunol; 1998 Feb; 160(3):1419-26. PubMed ID: 9570562
[TBL] [Abstract][Full Text] [Related]
5. Fluorescent ligands of the bradykinin B1 receptors: pharmacologic characterization and application to the study of agonist-induced receptor translocation and cell surface receptor expression.
Bawolak MT; Gera L; Morissette G; Bouthillier J; Stewart JM; Gobeil LA; Lodge R; Adam A; Marceau F
J Pharmacol Exp Ther; 2009 Apr; 329(1):159-68. PubMed ID: 19136639
[TBL] [Abstract][Full Text] [Related]
6. A nonpeptide antagonist reveals a highly glycosylated state of the rabbit kinin B1 receptor.
Fortin JP; Dziadulewicz EK; Gera L; Marceau F
Mol Pharmacol; 2006 Apr; 69(4):1146-57. PubMed ID: 16407468
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human and rabbit arterial smooth muscle cell migration mediated by the kinin B1 receptor: role of receptor density and released mediators.
Morissette G; Sabourin T; Adam A; Marceau F
Can J Physiol Pharmacol; 2006 Nov; 84(11):1107-19. PubMed ID: 17218975
[TBL] [Abstract][Full Text] [Related]
8. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin.
Tropea MM; Gummelt D; Herzig MS; Leeb-Lundberg LM
J Pharmacol Exp Ther; 1993 Feb; 264(2):930-7. PubMed ID: 8382284
[TBL] [Abstract][Full Text] [Related]
9. SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization.
Gougat J; Ferrari B; Sarran L; Planchenault C; Poncelet M; Maruani J; Alonso R; Cudennec A; Croci T; Guagnini F; Urban-Szabo K; Martinolle JP; Soubrié P; Finance O; Le Fur G
J Pharmacol Exp Ther; 2004 May; 309(2):661-9. PubMed ID: 14747609
[TBL] [Abstract][Full Text] [Related]
10. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
[TBL] [Abstract][Full Text] [Related]
11. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta.
Fortin JP; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
J Pharmacol Exp Ther; 2005 Sep; 314(3):1169-76. PubMed ID: 15919764
[TBL] [Abstract][Full Text] [Related]
12. Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors.
Levesque L; Drapeau G; Grose JH; Rioux F; Marceau F
Br J Pharmacol; 1993 Aug; 109(4):1254-62. PubMed ID: 8104648
[TBL] [Abstract][Full Text] [Related]
13. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism.
Gera L; Fortin JP; Adam A; Stewart JM; Marceau F
J Pharmacol Exp Ther; 2006 Apr; 317(1):300-8. PubMed ID: 16368899
[TBL] [Abstract][Full Text] [Related]
15. Evidence of a bradykinin B1 receptor in human ileum: pharmacological comparison to the rabbit aorta B1 receptor.
Zuzack JS; Burkard MR; Cuadrado DK; Greer RA; Selig WM; Whalley ET
J Pharmacol Exp Ther; 1996 Jun; 277(3):1337-43. PubMed ID: 8667195
[TBL] [Abstract][Full Text] [Related]
16. A non-peptide antagonist unusually selective for the human form of the bradykinin B2 receptor.
Marceau F; Fortin JP; Morissette G; Dziadulewicz EK
Int Immunopharmacol; 2003 Oct; 3(10-11):1529-36. PubMed ID: 12946450
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin B1 receptor expression induced by tissue damage in the rat portal vein: a critical role for mitogen-activated protein kinase and nuclear factor-kappaB signaling pathways.
Medeiros R; Cabrini DA; Ferreira J; Fernandes ES; Mori MA; Pesquero JB; Bader M; Avellar MC; Campos MM; Calixto JB
Circ Res; 2004 May; 94(10):1375-82. PubMed ID: 15087417
[TBL] [Abstract][Full Text] [Related]
18. Structural modification of the highly potent peptide bradykinin B1 receptor antagonist B9958.
Gera L; Stewart JM; Fortin JP; Morissette G; Marceau F
Int Immunopharmacol; 2008 Feb; 8(2):289-92. PubMed ID: 18182242
[TBL] [Abstract][Full Text] [Related]
19. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.
Drapeau G; Audet R; Levesque L; Godin D; Marceau F
J Pharmacol Exp Ther; 1993 Jul; 266(1):192-9. PubMed ID: 8392550
[TBL] [Abstract][Full Text] [Related]
20. Bradykinin activates R-, T-, and L-type Ca2+ channels and induces a sustained increase of nuclear Ca2+ in aortic vascular smooth muscle cells.
Bkaily G; Jaalouk D; Jacques D; Economos D; Hassan G; Simaan M; Regoli D; Pothier P
Can J Physiol Pharmacol; 1997 Jun; 75(6):652-60. PubMed ID: 9276144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]